HOME >> MEDICINE >> NEWS
One-on-one with pharmacists gives patients medication advantage

COLUMBUS, Ohio - After spending nearly an hour talking one-on-one with a pharmacist, participants in a new study reported using fewer medications and having far fewer drug-related problems.

Instead of having the subjects come to a pharmacy, the pharmacists came to the participants' churches.

Holding the one-on-one discussions at churches allowed people to come to an "emotionally safe, familiar and private environment, instead of the sometimes chaotic setting of a doctor's office or pharmacy," said Gerald Cable, a study co-author and a clinical assistant professor of pharmacy at Ohio State University.

"We weren't surprised at the extent of correctable medication problems we found," he said. "However, we were surprised that the participants were so willing to talk with us about these problems." More than half of the participants had kept medication past its expiration date, and nearly half reported that they had experienced adverse drug reactions.

But the intervention sessions seemed to help, as subjects reported using less medication during the six months after the one-on-one meeting than in the six months prior to the session.

"We hope that's a reflection of increased communication between the study participants an
'"/>

Contact: Gerald Cable
Cable.1@osu.edu
614-292-2492
Ohio State University
3-Jun-2002


Page: 1 2 3 4 5

Related medicine news :

1. UNC study uncovers increasing shortage of pharmacists with growing population
2. Specialist care gives better rate of survival
3. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
4. Kinder, gentler procedure gives superior results for stem cell transplants
5. Marine snail study gives insights into human brain
6. Mouse model gives insight to human hair loss
7. CT with multiplanar reconstruction gives new perspective on complex ankle fractures
8. ESA gives green light to funding for GMES
9. How brain gives special resonance to emotional memories
10. Off-label use of migraine drug gives children relief, study says
11. Study gives lowdown on high-temperature superconductivity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
Cached News: